Latest Stock Split Details
Key information about Processa Pharmaceuticals, Inc.'s most recent stock split
Split Date: 2025-12-17
Split Ratio: 1:25
Price Before Split: $0.27
Price After Split: $0.01
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 25.00 times fewer shares (a 1:25 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Processa Pharmaceuticals, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2025-12-17 | 1:25 | Yes | $0.27 | $0.01 |
| 2024-01-22 | 1:20 | Yes | $0.13 | $0.01 |
| 2019-12-23 | 1:7 | Yes | $2.14 | $0.31 |
| 2017-12-08 | 1:7 | Yes | $0.07 | $0.01 |
About Processa Pharmaceuticals, Inc.
Company overview and industry information
Processa Pharmaceuticals, Inc. (PCSA) operates in the Biotechnology industry. The recent 1-for-25 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Processa Pharmaceuticals, Inc. Summary